the antibacterial efficacy of some of the newer quinolone antimicrobial agents in general , and ciprofloxacin in particular , in animal models of experimental septic arthritis , burn wound sepsis , empyema , chronic gastroenteritis , granuloma pouch infection , intraabdominal abscess , osteomyelitis , prostatis , sinusitis , urinary tract infection , and severe septicemia caused by pseudomonas aeruginosa is reviewed .
C1533693
antibacterial
C1136254
antimicrobial